-
Blooms celebrates its best
Monday | Nov 3 2025BLOOMS The Chemist held its 2025 Partner’s Conference last week on the Gold Coast, with individual owners coming together for professional development and to celebrate excellence and achievements within the network.
-
Modern lifestyle driving headache burden
Monday | Nov 3 2025MORE than a third of the world’s population experience migraines and headache disorders, according to a comprehensive analysis of the global impact of the conditions.
-
Emergency med
Monday | Nov 3 2025NOVA Pharmaceuticals’ emergency contraception Novella-1 is available to order for dispensing by pharmacists.
-
Design your space
Monday | Nov 3 2025PHARMACIUM will create work spaces that reflect your working style and improve efficiencies throughout your pharmacy, with a focus on dispensary operations.
-
Hodgkin lymphoma drug Adcetris on PBS
Monday | Nov 3 2025ADCETRIS (brentuximab vedotin, Takeda) has been listed on the Pharmaceutical Benefits Scheme (PBS) for first-line treatment, in combination with chemotherapy, in people with CD30 Stage III or Stage IV Hodgkin lymphoma.
-
EPA’s microbead crackdown
Monday | Nov 3 2025BEAUTY brands supplying personal care products containing plastic microbeads have been ordered to stop, as the NSW Environment Protection Authority (EPA) ramps up enforcement of the state’s plastics bans.
-
Important to listen to concerns over COVID vaccines to build trust
Monday | Nov 3 2025RESEARCH conducted in the UK has found that a disconnect between scientific discussions around the potential benefits and risks of vaccines versus long COVID and public health messaging can hinder trust, especially after unexpected or adverse vaccine experiences.
-
Dispensary Corner 03 Nov 25
Monday | Nov 3 2025DON’T tell these big beautiful bears about the benefits of Ozempic or Mounjaro.
-
PD for Mon 03 Nov 2025
Monday | Nov 3 2025Blooms holds its annual conference, headache disorders affect 2.8 billion globally, long COVID experience affects vaccine trust, and more
-
Prescribing: time for talk is over
Friday | Oct 31 2025AT A national forum on a pharmacist’s endorsement for scheduled medicines, hosted by the Pharmacy Board of Australia yesterday, pharmacy peak bodies reaffirmed their strong support for a model of autonomous pharmacist prescribing within a self-determined, documented, and authorised scope of practice.
Subscribe to Pharmacy Daily now!
FREE Pharmacy Daily subscription - never miss another story!
to top
